v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Cash flows from operating activities:    
Net income $ 417,415 $ 406,436
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 39,625 32,993
Deferred income taxes (17,274) (1,967)
Depreciation 66,211 64,680
Amortization of intangibles 87,485 78,570
Change in operating assets and liabilities:    
Decrease in accounts receivable 26,122 27,457
Increase in inventories (65,956) (2,032)
(Increase) decrease in other current assets (9,753) 1,279
Decrease (increase) in other assets 41,324 (18,416)
(Decrease) increase in accounts payable and other current liabilities (114,249) 36,485
Increase in deferred revenue and customer advances 34,071 37,972
Decrease in other liabilities (17,019) (141,473)
Net cash provided by operating activities 488,002 521,984
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (73,772) (90,377)
Business acquisitions, net of cash acquired (35,053) 0
Investments in unaffiliated companies, net (1,295) (1,489)
Purchases of investments 0 (2,796)
Maturities and sales of investments 0 2,752
Net cash used in investing activities (110,120) (91,910)
Cash flows from financing activities:    
Proceeds from debt issuances 70,000 170,000
Payments on debt (290,000) (700,000)
Payments of debt issuance costs (22,986) 0
Proceeds from stock plans 15,621 25,073
Purchases of treasury shares (14,523) (13,475)
Proceeds from derivative contracts 1,347 15,305
Net cash used in financing activities (240,541) (503,097)
Effect of exchange rate changes on cash and cash equivalents (3,578) 8,461
Increase (decrease) in cash and cash equivalents 133,763 (64,562)
Cash and cash equivalents at beginning of period 325,355 395,076
Cash and cash equivalents at end of period $ 459,118 $ 330,514